Real-time enrollment status for this colorectal cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 1:53 PM UTC
| NCT Number | NCT06252649 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Cancer |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 15, 2026: Clinical trial NCT06252649 is currently recruiting participants. This phase3 study for colorectal cancer is actively seeking new participants at 26 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06252649 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06252649 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.